Traitements potentiels

A living WHO guideline on drugs for covid-19, BMJ 2020; 370 doi: https://doi.org/10.1136/bmj.m3379 (Published 04 September 2020)

ALGORITHME DE TRAITEMENTS CONTRE LA COVID-19 EN AMBULATOIRE POUR LES PERSONNES À RISQUE ÉLEVÉ DE COMPLICATIONS, INESSS, Mars 2022

TRAITEMENTS SPÉCIFIQUES À LA COVID-19, INESSS

Treatment of patients with nonsevere and severe coronavirus disease 2019: an evidence-based guideline, CMAJ 2020. doi: 10.1503/cmaj.200648; early-released April 29, 2020

Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results, NEJM, December 2, 2020, DOI: 10.1056/NEJMoa2023184

NIH COVID-19 Treatment Guidelines

Ten Weeks to Crush the Curve, April 23, 2020, N Engl J Med 2020; 382:e37, DOI: 10.1056/NEJMe2007263

Anticorps

Subcutaneous REGEN-COV Antibody Combination to Prevent Covid-19, NEJM, August 4, 2021, DOI: 10.1056/NEJMoa2109682

Dexaméthasone

Corticosteroids for COVID-19, WHO

Association Between Administration of Systemic Corticosteroids and Mortality Among Critically Ill Patients With COVID-19, A Meta-analysis, The WHO Rapid Evidence Appraisal for COVID-19 Therapies (REACT) Working Group, JAMA. Published online September 2, 2020. doi:10.1001/jama.2020.17023

Dexamethasone in Hospitalized Patients with Covid-19 — Preliminary Report The RECOVERY Collaborative Group*, NEJM, July 17, 2020, DOI: 10.1056/NEJMoa2021436

Plasma Convalescent

A randomized trial of convalescent plasma in Covid-19 severe pneumonia. Simonovich VA et al. N Engl J Med 2020 Nov 24; [e-pub]. (https://doi.org/10.1056/NEJMoa2031304)

Effect of Convalescent Plasma Therapy on Viral Shedding and Survival in COVID-19 Patients, Qing-Lei Zeng, Zu-Jiang Yu, Jian-Jun Gou, Guang-Ming Li, Shu-Huan Ma, Guo-Fan Zhang, Jiang-Hai Xu, Wan-Bao Lin, Guang-Lin Cui, Min-Min Zhang, The Journal of Infectious Diseases, jiaa228, https://doi.org/10.1093/infdis/jiaa22

Remdesivir

COVID 19 Usage optimal du Remdésivir, INESS

Remdesivir for the Treatment of Covid-19 — Final Report, NEJM, October 8, 2020, DOI: 10.1056/NEJMoa2007764

Remdesivir for the Treatment of Covid-19 — Preliminary Report, NEJM, May 22, 2020, DOI: 10.1056/NEJMoa2007764

Remdesivir Now 'Standard of Care' for COVID-19, Fauci Says

Compassionate Use of Remdesivir for Patients with Severe Covid-19, NEJM, April 10, 2020, DOI: 10.1056/NEJMoa2007016